Pfizer 'very close' to applying for US emergency approval, says CEO

The pharmaceutical giant announced last week preliminary results from a late-stage clinical trial showing the injections it had co-developed with Germany's BioNTech was more than 90 percent effective after the second dose.

from International-News-Economic Times https://ift.tt/2KkfIqH
via IFTTT

SHARE